Greenwich Wealth Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Greenwich Wealth Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-76,341	Closed	-$295K	–	266
2024 Q3	$295K	Hold	76,341	–	–	0.02%	201
2024 Q2	$177K	Hold	76,341	–	–	0.01%	228
2024 Q1	$215K	Hold	76,341	–	–	0.02%	218
2023 Q4	$243K	Hold	76,341	–	–	0.02%	197
2023 Q3	$252K	Buy	76,341 +27,339	+56%	+$85.2K	0.03%	194
2023 Q2	$162K	Buy	49,002 +18,974	+63%	+$67K	0.02%	217
2023 Q1	$99K	Buy	+30,028	New	+$105K	0.01%	224

Greenwich Wealth Management's LUMO Position: Q4 2024 in Review

Greenwich Wealth Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 76,341 shares — an estimated $295K sold.

Greenwich Wealth Management first reported a position in LUMO in Q1 2023 and held it in 7 quarters. The position peaked at $295K in Q3 2024. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

Greenwich Wealth Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Greenwich Wealth Management sold 76,341 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $295K.
Greenwich Wealth Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
Greenwich Wealth Management's Lumos Pharma, Inc. Common Stock position peaked at $295K in Q3 2024.
0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Greenwich Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.